Clinicopathological features and prognosis of patients with HER2-low breast cancer

BACKGROUND: Low human epidermal growth factor receptor 2 (HER2) expression is an emerging concept in breast cancer that is defined as immunohistochemistry (IHC) 1 + or IHC 2 + and negative in situ hybridization (ISH) but has been poorly investigated. The aim of our study was to determine the frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xin, Li, Yao, lu, Xu, Ren, Xiaotian, Hua, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537579/
https://www.ncbi.nlm.nih.gov/pubmed/37770874
http://dx.doi.org/10.1186/s12885-023-11421-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537579/
https://www.ncbi.nlm.nih.gov/pubmed/37770874
http://dx.doi.org/10.1186/s12885-023-11421-0

Ejemplares similares